The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease

(2016) Quentin M. Anstee et al.   GASTROENTEROLOGY

Clinical and metabolic characteristics of treated hyperlipidemic patients additionally affected by subclinical hyperglycemia

(2016) Michael Leutner et al.   Lipids in Health and Disease

Genetics of nonalcoholic fatty liver disease

(2016) Paola Dongiovanni et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Non-alcoholic fatty liver disease and dyslipidemia: An update

(2016) Niki Katsiki et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD

(2016) Newaz Hossain et al.   Gastroenterology Research and Practice

Phenotypes of prediabetes and stratification of cardiometabolic risk

(2016) Norbert Stefan et al.   Lancet Diabetes & Endocrinology

Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

(2016) Xi-Xi He et al.   PLoS One

Type and amount of dietary protein in the treatment of metabolic syndrome: a randomized controlled trial

(2015) Alison M Hill et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals

(2014) Catherine E. de Keyser et al.   DIGESTIVE AND LIVER DISEASE

New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease

(2014) Amirhossein Sahebkar et al.   EXPERT OPINION ON PHARMACOTHERAPY

Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice

(2013) Anouk Funke et al.   ATHEROSCLEROSIS

External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study

(2013) Edith M. Koehler et al.   Clinical Gastroenterology and Hepatology

Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans

(2013) Norbert Stefan et al.   NATURE MEDICINE

The role of hepatokines in metabolism

(2013) Norbert Stefan et al.   Nature Reviews Endocrinology

Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes

(2012) Latife Bozkurt et al.   PLoS One

Prevalence and risk factors of diabetes and impaired fasting glucose in Nauru

(2011) Amina Khambalia et al.   BMC PUBLIC HEALTH

Fatty liver index as an indicator of metabolic syndrome

(2011) Dinko Rogulj et al.   CLINICAL BIOCHEMISTRY

Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease

(2011) Giovanni Musso et al.   CURRENT OPINION IN LIPIDOLOGY

Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes: A 4-year retrospective longitudinal study

(2011) J. C. Bae et al.   DIABETES CARE

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Impact of liver diseases on the development of type 2 diabetes mellitus

(2011) Po-Shiuan Hsieh   WORLD JOURNAL OF GASTROENTEROLOGY

Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study

(2010) Beverley Balkau et al.   BMC GASTROENTEROLOGY

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study

(2010) Elizabeth K. Speliotes et al.   HEPATOLOGY

A position statement on NAFLD/NASH based on the EASL 2009 special conference

(2010) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

(2010) Giovanni Targher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anthropometric, metabolic, dietary and psychosocial profiles of underreporters of energy intake: a doubly labeled water study among overweight/obese postmenopausal women—a Montreal Ottawa New Emerging Team study

(2009) A D Karelis et al.   EUROPEAN JOURNAL OF CLINICAL NUTRITION

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

(2009) Amalia Gastaldelli et al.   HEPATOLOGY

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

(2009) E. Fabbrini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Identification and Characterization of Metabolically Benign Obesity in Humans

(2008) Norbert Stefan   ARCHIVES OF INTERNAL MEDICINE

Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults

(2008) C.-H. Kim et al.   DIABETIC MEDICINE

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: A systematic review

(2008) Silvia Sookoian et al.   JOURNAL OF HEPATOLOGY

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive

(2008) Anna Wieckowska et al.   SEMINARS IN LIVER DISEASE